4.8 Article

Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract Epicardium

期刊

CIRCULATION
卷 123, 期 12, 页码 1270-U38

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.110.972612

关键词

Brugada syndrome; catheter ablation; arrhythmia; electrophysiology; mapping

资金

  1. CAPRE
  2. Vejdusit Foundation of Thailand
  3. Adventis Health Organization at White Memorial Hospital
  4. Biosense-Cordis Webster Inc.
  5. Medtronic Inc.
  6. Biosense Webster Inc.

向作者/读者索取更多资源

Background-The underlying electrophysiological mechanism that causes an abnormal ECG pattern and ventricular tachycardia/ventricular fibrillation (V(T)/VF) in patients with the Brugada syndrome (BrS) remains unelucidated. However, several studies have indicated that the right ventricular outflow tract (RVOT) is likely to be the site of electrophysiological substrate. We hypothesized that in patients with BrS who have frequent recurrent VF episodes, the substrate site is the RVOT, either over the epicardium or endocardium; abnormal electrograms would be identified at this location, which would serve as the target site for catheter ablation. Methods and Results-We studied 9 symptomatic patients with the BrS (all men; median age 38 years) who had recurrent VF episodes (median 4 episodes) per month, necessitating implantable cardioverter defibrillator discharge. Electroanatomic mapping of the right ventricle, both endocardially and epicardially, and epicardial mapping of the left ventricle were performed in all patients during sinus rhythm. All patients had typical type 1 Brugada ECG pattern and inducible V(T)/VF; they were found to have unique abnormal low voltage (0.94 +/- 0.79 mV), prolonged duration (132 +/- 48 ms), and fractionated late potentials (96 +/- 47 ms beyond QRS complex) clustering exclusively in the anterior aspect of the RVOT epicardium. Ablation at these sites rendered V(T)/VF noninducible (7 of 9 patients [78%]; 95% confidence interval, 0.40 to 0.97, P=0.015) and normalization of the Brugada ECG pattern in 89% (95% confidence interval, 0.52 to 0.99; P=0.008). Long-term outcomes (20 +/- 6 months) were excellent, with no recurrent V(T)/VF in all patients off medication (except 1 patient on amiodarone). Conclusions-The underlying electrophysiological mechanism in patients with BrS is delayed depolarization over the anterior aspect of the RVOT epicardium. Catheter ablation over this abnormal area results in normalization of the Brugada ECG pattern and prevents V(T)/VF, both during electrophysiological studies as well as spontaneous recurrent V(T)/VF episodes in patients with BrS. (Circulation. 2011;123:1270-1279.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据